IMPORTANCE: Few studies have assessed the effects of daily vitamin D doses at or above the tolerable upper intake level for 12 months or greater, yet 3% of US adults report vitamin D intakes of at least 4000 IU per day.
OBJECTIVE: To assess the dose-dependent effect of vitamin D supplementation on volumetric bone mineral density (BMD) and strength.
DESIGN, SETTING, AND PARTICIPANTS: Three-year, double-blind, randomized clinical trial conducted in a single center in Calgary, Canada, from August 2013 to December 2017, including 311 community-dwelling healthy adults without osteoporosis, aged 55 to 70 years, with baseline levels of 25-hydroxyvitamin D (25[OH]D) of 30 to 125 nmol/L.
INTERVENTIONS: Daily doses of vitamin D3 for 3 years at 400 IU (n = 109), 4000 IU (n = 100), or 10 000 IU (n = 102). Calcium supplementation was provided to participants with dietary intake of less than 1200 mg per day.
MAIN OUTCOMES AND MEASURES: Co-primary outcomes were total volumetric BMD at radius and tibia, assessed with high resolution peripheral quantitative computed tomography, and bone strength (failure load) at radius and tibia estimated by finite element analysis.
RESULTS: Of 311 participants who were randomized (53% men; mean [SD] age, 62.2 [4.2] years), 287 (92%) completed the study. Baseline, 3-month, and 3-year levels of 25(OH)D were 76.3, 76.7, and 77.4 nmol/L for the 400-IU group; 81.3, 115.3, and 132.2 for the 4000-IU group; and 78.4, 188.0, and 144.4 for the 10 000-IU group. There were significant group × time interactions for volumetric BMD. At trial end, radial volumetric BMD was lower for the 4000 IU group (−3.9 mg HA/cm3 [95% CI, −6.5 to −1.3]) and 10 000 IU group (−7.5 mg HA/cm3 [95% CI, −10.1 to −5.0]) compared with the 400 IU group with mean percent change in volumetric BMD of −1.2% (400 IU group), −2.4% (4000 IU group), and −3.5% (10 000 IU group). Tibial volumetric BMD differences from the 400 IU group were −1.8 mg HA/cm3 (95% CI, −3.7 to 0.1) in the 4000 IU group and −4.1 mg HA/cm3 in the 10 000 IU group (95% CI, −6.0 to −2.2), with mean percent change values of −0.4% (400 IU), −1.0% (4000 IU), and −1.7% (10 000 IU). There were no significant differences for changes in failure load (radius, P = .06; tibia, P = .12).
CONCLUSIONS AND RELEVANCE: Among healthy adults, treatment with vitamin D for 3 years at a dose of 4000 IU per day or 10 000 IU per day, compared with 400 IU per day, resulted in statistically significant lower radial BMD; tibial BMD was significantly lower only with the 10 000 IU per day dose. There were no significant differences in bone strength at either the radius or tibia. These findings do not support a benefit of high-dose vitamin D supplementation for bone health; further research would be needed to determine whether it is harmful.
TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01900860
|2010||Papaioannou A, Morin S, Cheung AM, Atkinson S, Brown JP, Feldman S, Hanley DA, Hodsman A, Jamal SA, Kaiser SM, Kvern B, Siminoski K, Leslie WD; Scientific Advisory Council of Osteoporosis Canada. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. Can Med Assoc J. November 23, 2010;182(17):1864-1873.|
|2019||Samelson EJ, Broe KE, Xu H, Yang L, Boyd S, Biver E, Szulc P, Adachi J, Amin S, Atkinson E, Berger C, Burt L, Chapurlat R, Chevalley T, Ferrari S, Goltzman D, Hanley DA, Hannan MT, Khosla S, Liu C-T, Lorentzon M, Mellstrom D, Merle B, Nethander M, Rizzoli R, Sornay-Rendu E, Van Rietbergen B, Sundh D, Wong AKO, Ohlsson C, Demissie S, Kiel DP, Bouxsein ML. Cortical and trabecular bone microarchitecture as an independent predictor of incident fracture risk in older women and men in the Bone Microarchitecture International Consortium (BoMIC): a prospective study. Lancet Diabetes Endocrinol. January 2019;7(1):34-43.|
|2020||Chakhtoura M, Chamoun N, Rahme M, Fuleihan GE-H. Impact of vitamin D supplementation on falls and fractures: a critical appraisal of the quality of the evidence and an overview of the available guidelines. Bone. February 2020;131.|
|2021||Whittier DE, Burt LA, Boyd SK. A new approach for quantifying localized bone loss by measuring void spaces. Bone. February 2021;143:115785.|
|2021||Mikolajewicz N, Zimmermann EA, Rummler M, Hosseinitabatabaei S, Julien C, Glorieux FH, Rauch F, Willie BM. Multisite longitudinal calibration of HR-pQCT scanners and precision in osteogenesis imperfecta. Bone. June 2021;147:115880.|
|2020||Zhang Y, Liu Z, Duan L, Ji Y, Yang S, Zhang Y, Li H, Wang Y, Wang P, Chen J, Li Y. Effect of low-dose vitamin K2 supplementation on bone mineral density in middle-aged and elderly Chinese: a randomized controlled study. Calcif Tiss Int. May 2020;106(5):476-485.|
|2020||LeBoff MS, Chou SH, Murata EM, Donlon CM, Cook NR, Mora S, Lee I, Kotler G, Bubes V, Buring JE, Manson JE. Effects of supplemental vitamin D on bone health outcomes in women and men in the VITamin D and OmegA‐3 TriaL (VITAL). J Bone Miner Res. May 2020;35(5):883-893.|
|2020||Whittier DE, Burt LA, Hanley DA, Boyd SK. Sex‐ and site‐specific reference data for bone microarchitecture in adults measured using second‐generation HR‐pQCT. J Bone Miner Res. November 2020;35(11):2151-2158.|
|2020||Burt LA, Billington EO, Rose MS, Kremer R, Hanley DA, Boyd SK. Adverse effects of high‐dose vitamin D supplementation on volumetric bone density are greater in females than males. J Bone Miner Res. December 2020;35(12):2404-2414.|
|2021||Sugiyama T. Effects of high‐dose vitamin d supplementation on bone fragility. J Bone Miner Res. March 2021;36(3):621-621.|
|2021||Burt LA, Billington EO, Rose MS, Kremer R, Hanley DA, Boyd SK. Reply to effects of high‐dose vitaminD supplementation on bone fragility. J Bone Miner Res. March 2021;36(3):622-622.|
|2020||Javaid MK, Sami A, Lems W, Mitchell P, Thomas T, Singer A, Speerin R, Fujita M, Pierroz DD, Akesson K, Halbout P, Ferrari S, Cooper C. A patient-level key performance indicator set to measure the effectiveness of fracture liaison services and guide quality improvement: a position paper of the IOF Capture the Fracture Working Group, National Osteoporosis Foundation and Fragility Fracture Network. Osteoporos Int. July 2020;31(7):1193-1204.|
|2020||Whittier DE, Boyd SK, Burghardt AJ, Paccou J, Ghasem-Zadeh A, Chapurlat R, Engelke K, Bouxsein ML. Guidelines for the assessment of bone density and microarchitecture in vivo using high-resolution peripheral quantitative computed tomography. Osteoporos Int. September 2020;31(9):1607-1627.|
|2020||Aul AJ, Dudenkov DV, Mara KC, Juhn YJ, Wi CI, Maxson JA, Thacher TD. The relationship of 25-hydroxyvitamin D values and risk of fracture: a population-based retrospective cohort study. Osteoporos Int. September 2020;31(9):1787-1799.|
|2020||Kemp TD, de Bakker CMJ, Gabel L, Hanley DA, Billington EO, Burt LA, Boyd SK. Longitudinal bone microarchitectural changes are best detected using image registration. Osteoporos Int. October 2020;31(10):1995-2005.|
|2020||Billington EO, Burt LA, Plett R, Rose MS, Boyd SK, Hanley DA. Effect of high-dose vitamin D supplementation on peripheral arterial calcification: secondary analysis of a randomized controlled trial. Osteoporos Int. November 2020;31(11):2141-2150.|
|2020||Plett RM. Enhanced Longitudinal Analysis of Bone Strength Estimated by 3D Bone Imaging and the Finite Element Method [Master's thesis]. Calgary, AB: University of Calgary; October 2020.|
|2020||Spanswick P. Using HR-PQCT and Finite Element Analysis to Inform Clinical Assessment of Distal Radius Fractures [Master's thesis]. Calgary, AB: University of Calgary; August 2020.|